Moderna Tumbles On Report Of Delayed COVID Vaccine Trial
July 02, 2020 at 14:10 PM EDT
Moderna shares are down 7% following headlines that its virus vaccine trial has been delayed.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|